| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $3.18B | +12.6% |
| Cost of Revenue | $2.13B | +13.2% |
| Gross Profit | $1.06B | +11.4% |
| R&D Expense | $36.7M | +44.5% |
| Interest Expense | $121.5M | +56.4% |
| Pre-tax Income | -$139.4M | -164.3% |
| Income Tax | $64.8M | -37.0% |
| Net Income | -$211.0M | -137.0% |
| EPS (Basic) | -$3.00 | -136.8% |
| EPS (Diluted) | -$3.00 | -136.9% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $199.3M | -17.9% |
| Inventory | $525.2M | -11.4% |
| Current Assets | $1.51B | -6.1% |
| Total Assets | $5.24B | -5.6% |
| Current Liabilities | $1.19B | -7.9% |
| Long-term Debt | $1.89B | -5.8% |
| Total Liabilities | $3.78B | -2.7% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Financing Cash Flow | -$227.1M | -132.8% |
| Stockholders' Equity |
| $1.42B |
| -12.7% |